or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Public Statements

Date Title Officials Location
May 17, 2013 Pitts, Schakowsky, Whitfield and Eshoo Introduce Bill to End Doping of Racehorses Rep. Joseph Pitts Unknown
May 8, 2013 Letter to Margaret A. Hamburg - Commissioner U.S. Food and Drug Administration Rep. Timothy Murphy Washington, DC
May 6, 2013 Letter to Dr. Margaret Hamburg, Commissioner for the U.S. Food and Drug Administration - End Infant Drug Shortage Sen. Robert Casey Unknown
May 3, 2013 Letter to Mary Jane Helenek, President and CEO of Luitpold Pharmaceuticals, Inc., Michael Ball, CEO of Hospira Inc., and John Ducker, President and CEO of APP Pharmaceuticals - End Shortage of Critical Drugs Used to Treat Infants in Intensive Care Sen. Robert Casey Washington, DC
April 18, 2013 Letter to U.S. Secretary of State John Kerry - U.S.-Colombia Policy Rep. Chaka Fattah Unknown
April 18, 2013 Letter to U.S. Secretary of State John Kerry - U.S.-Colombia Policy Rep. Matthew Cartwright Unknown
April 18, 2013 Letter to U.S. Secretary of State John Kerry - U.S.-Colombia Policy Rep. Joseph Pitts Unknown
March 22, 2013 Casey Introduces Bill to Combat Dangerous Trend of Cough Syrup Abuse Among Teens Sen. Robert Casey Washington, DC
Feb. 6, 2013 Fitzpatrick Honored For Drug Abuse Prevention Efforts Rep. Michael Fitzpatrick Washington, DC
June 22, 2012 In Springfield, Meehan Highlights Legislation to Crackdown on Counterfeit Rx Drug Trafficking Rep. Patrick Meehan Springfield, PA
June 20, 2012 House Passes Bill to Ban Synthetic Drugs Rep. Charles Dent Washington, DC
June 20, 2012 Murphy's Generic Drug Bill One Step Closer to Becoming Law Rep. Timothy Murphy Washington, DC
June 20, 2012 Food and Drug Administration Safety and Innovation Act Rep. Timothy Murphy Washington, DC
June 20, 2012 Food and Drug Administration Safety and Innovation Act Rep. Joseph Pitts Washington, DC
June 20, 2012 Food and Drug Administration Safety and Innovation Act Rep. Charles Dent Washington, DC
June 19, 2012 Casey: Agreement Reached on Banning Bath Salts Sen. Robert Casey Washington, DC
June 18, 2012 Meehan Bill to Crackdown on Counterfeit Rx Drug Trafficking Passes House Rep. Patrick Meehan Washington, DC
June 18, 2012 Counterfeit Drug Penalty Enhancement Act of 2012 Rep. Patrick Meehan Washington, DC
June 15, 2012 Letter to The Honorable Tom Harkin, Chairman, Committee on Health, Education, Labor, and Pensions; The Honorable Michael B. Enzi, Ranking Member, Committee on Health, Education, Labor, and Pensions; The Honorable Fred Upton, Chairman, Committee on Energy and Commerce; The Honorable Henry A. Waxman, Ranking Member, Committee on Energy and Commerce Sen. Robert Casey Washington, DC
June 15, 2012 Letter to the Honorable Tom Harkin, Chairman on the Committee on Health, Education, Labor, and Pensions, the Honorable Michael B. Enzi, Ranking Member Committee on Health, Education, Labor, and Pensions, the Honorable Fred Upton, Chairman on the Committee on Energy and Commerce, and the Honorable Henry A. Waxman Ranking Member Committee on Energy and Commerce Sen. Robert Casey Washington, DC
June 12, 2012 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy &Commerce, The Honorable Tom Harkin, Chairman of the Committee on Health, Education, Labor &Pensions, and the Honorable Henry A. Waxman, Ranking Member of the Committee on Energy and Commerce, The Honorable Michael B. Enzi, Ranking Member of the Committee on Health, Education, Labor & Pensions Rep. Michael Fitzpatrick Washington, DC
June 12, 2012 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy &Commerce, The Honorable Tom Harkin, Chairman of the Committee on Health, Education, Labor &Pensions, and the Honorable Henry A. Waxman, Ranking Member of the Committee on Energy and Commerce, The Honorable Michael B. Enzi, Ranking Member of the Committee on Health, Education, Labor & Pensions Rep. Thomas Marino Washington, DC
June 12, 2012 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy &Commerce, The Honorable Tom Harkin, Chairman of the Committee on Health, Education, Labor &Pensions, and the Honorable Henry A. Waxman, Ranking Member of the Committee on Energy and Commerce, The Honorable Michael B. Enzi, Ranking Member of the Committee on Health, Education, Labor & Pensions Rep. Charles Dent Washington, DC
June 12, 2012 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy &Commerce, The Honorable Tom Harkin, Chairman of the Committee on Health, Education, Labor &Pensions, and the Honorable Henry A. Waxman, Ranking Member of the Committee on Energy and Commerce, The Honorable Michael B. Enzi, Ranking Member of the Committee on Health, Education, Labor & Pensions Rep. Bill Shuster Washington, DC
June 6, 2012 House Judiciary Committee Approves Meehan Bill to Crackdown on Counterfeit Drugs Rep. Patrick Meehan Washington, DC
June 5, 2012 Letter The Honorable Marilyn Tavenner, Acting Administrator, Centers for Medicare and Medicaid Services Sen. Robert Casey Washington, DC
June 5, 2012 Letter to Chairman Harkin, Ranking Member Enzi, Chairman Upton, and Ranking Member Waxman Sen. Robert Casey Washington, DC
May 31, 2012 Schwartz Lauds Passage of Bipartisan Legislation to Ensure Access to Critical Medicines and Medical Devices Rep. Allyson Schwartz Washington, DC
May 31, 2012 House Passes Legislation to Help Prevent Drug Shortages Rep. Bill Shuster Washington, DC
May 30, 2012 Food and Drug Administration Reform Act of 2012 Rep. Timothy Murphy Washington, DC
May 30, 2012 Food and Drug Administration Reform Act of 2012 Rep. Joseph Pitts Washington, DC
May 29, 2012 Meehan Calls on Senate to Pass Nationwide Ban on Synthetic Drugs Rep. Patrick Meehan Upper Merion, PA
May 25, 2012 Casey Proposals Pass Senate as Part of FDA Bill - Measures Will Protect Pennsylvanians, Boost Commonwealth's Thriving Medical Sector Sen. Robert Casey Washington, DC
May 18, 2012 Racing Out of Control Rep. Joseph Pitts Unknown
May 11, 2012 With Drug Costs On the Rise, Committee Approves Murphy Healthcare Bill Rep. Timothy Murphy Unknown
May 10, 2012 Energy and Commerce Committee Unanimously Approves FDA Legislation Rep. Joseph Pitts Unknown
April 30, 2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - A Review of Efforts to Protect the Health of Jockeys and Horses in Horseracing Rep. Joseph Pitts Washington, DC
April 24, 2012 Bipartisan Casey-Alexander Proposal to Combat Prescription Drug Abuse Advances in Senate Sen. Robert Casey Washington, DC
March 28, 2012 House Judiciary Hearing Focuses on Meehan's Bipartisan Anti-Counterfeit Drug Bill Rep. Patrick Meehan Washington, DC
March 21, 2012 Senator Toomey Receives Pennsylvania Bio Federal Public Official Of The Year Award Sen. Patrick Toomey Washington, DC
March 8, 2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - "FDA User Fees 2012: Hearing on Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development and Downstream Pharmaceutical Supply Chain Rep. Joseph Pitts Washington, DC
March 5, 2012 Grassley, Enzi, Hatch, Pitts Seek Details of Discount Drug Program Rep. Joseph Pitts Washington, DC
Feb. 17, 2012 Letter to Margaret Hamburg, M.D., Commissioner of U.S. Food and Drug Administration Sen. Robert Casey Washington, DC
Feb. 17, 2012 Letter to George Doyle III, President and Chief Operating Officer of Ben Venue Laboratories Sen. Robert Casey Washington, DC
Feb. 14, 2012 Klobuchar, Casey, Collins Offer Amendment to Push Urgent Drug Legislation Forward Sen. Robert Casey Washington, DC
Feb. 9, 2012 Members Introduce Bipartisan Legislation to Improve FDA Generic Drug Approvals Rep. Joseph Pitts Washington, DC
Feb. 9, 2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages Rep. Joseph Pitts Washington, DC
Feb. 9, 2012 Members Introduce Bipartisan Legislation to Improve FDA Generic Drug Approvals Rep. Timothy Murphy Washington, DC
Feb. 7, 2012 Rep. Marino Introduces Bill to Curb Foreign Drug Trafficking Rep. Thomas Marino Washington, DC
Feb. 1, 2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Reauthorization of PDUFA: What It Means for Jobs, Innovation, and Patients Rep. Joseph Pitts Washington, DC
Jan. 18, 2012 Letter to Pat Leahy, Senate Judiciary Committee Chairman Sen. Robert Casey Washington, DC
Dec. 16, 2011 Feinstein, Grassley Bill to Combat Transnational Organized Crime Passes the Senate Sen. Robert Casey Washington, DC
Dec. 15, 2011 New GAO Report Backs Casey Bill to Confront Drug Shortage Crisis Sen. Robert Casey Washington, DC
Dec. 8, 2011 Meehan Applauds House Passage of Bill to Ban Synthetic Drugs Rep. Patrick Meehan Washington, DC
Dec. 8, 2011 Dent Synthetic Drug Bill Passes House Rep. Charles Dent Washington, DC
Dec. 8, 2011 Rep. Barletta Praises Passage of Bath Salts Ban Rep. Louis Barletta Washington, DC
Dec. 7, 2011 Synthetic Drug Control Act of 2011 Rep. Patrick Meehan Washington, DC
Dec. 7, 2011 Synthetic Drug Control Act of 2011 Rep. Joseph Pitts Washington, DC
Dec. 7, 2011 Synthetic Drug Control Act of 2011 Rep. Thomas Marino Washington, DC
Dec. 7, 2011 Synthetic Drug Control Act of 2011 Rep. Charles Dent Washington, DC
Nov. 30, 2011 Third Annual Nationwide Drug Take-Back Day Rep. Michael Fitzpatrick Washington, DC
Nov. 29, 2011 Casey: Fix to Medicare Donut Hole Will Save Older Pennsylvanians More Than $87 Million Sen. Robert Casey Washington, DC
Nov. 21, 2011 Neuroscience Initiative Endorsed By Chair of National Drug Court Association Rep. Chaka Fattah Washington, DC
Nov. 20, 2011 Bill Boosting Penalties for Rx Drug Counterfeiting Rep. Patrick Meehan Unknown
Nov. 17, 2011 Meehan Introduces Bill Boosting Penalties for Rx Drug Counterfeiting Rep. Patrick Meehan Washington, DC
Nov. 15, 2011 Casey, Toomey and Critz Oppose Closure of NDIC Sen. Robert Casey Washington, DC
Nov. 15, 2011 Casey, Toomey and Critz Oppose Closure of NDIC Sen. Patrick Toomey Washington, DC
Nov. 7, 2011 Letter to Margaret Hamburg, Food and Drug Administration (FDA) Commissioner Rep. Jim Gerlach Washington, DC
Nov. 7, 2011 Letter to Margaret Hamburg, Food and Drug Administration (FDA) Commissioner Rep. Patrick Meehan Washington, DC
Nov. 7, 2011 Letter to Margaret Hamburg, Food and Drug Administration (FDA) Commissioner Rep. Charles Dent Washington, DC
Nov. 7, 2011 Letter to Margaret Hamburg, Food and Drug Administration (FDA) Commissioner Rep. Glenn Thompson Washington, DC
Nov. 4, 2011 Congress Has Not Been Waiting to Combat Drug Shortages Rep. Joseph Pitts Unknown
Nov. 3, 2011 Motion to Instruct Conferees on H.R. 2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 Rep. Chaka Fattah Washington, DC
Nov. 3, 2011 Dent Synthetic Drug Bill Passes Key Committee Rep. Charles Dent Washington, DC
Oct. 31, 2011 Letter to Senators Reid and McConnell Sen. Robert Casey Washington, DC
Oct. 31, 2011 Casey on White House Endorsement of His Bipartisan Bill to Address Drug Shortages Sen. Robert Casey Washington, DC
Oct. 27, 2011 Investigation Shows Chinese Firms Linked to Contaminated Drugs Still Supplying the U.S. Rep. Joseph Pitts Washington, DC
Oct. 19, 2011 Letter to The Honorable Darrell Issa, Chairman Committee on Oversight and Government Reform Rep. Robert Brady Washington, DC
Oct. 18, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2012 Sen. Robert Casey Washington, DC
Oct. 14, 2011 Letter to Co-Chairmen Murray and Hensarling of the Joint Select Committee on Deficit Reduction Rep. Louis Barletta Washington, DC
Oct. 14, 2011 Letter to Co-Chairmen Murray and Hensarling of the Joint Select Committee on Deficit Reduction Rep. Patrick Meehan Washington, DC
Oct. 5, 2011 Letter to The Honorable Kathleen Sebelius U.S. Department of Health and Human Services Sen. Patrick Toomey Washington, DC
Sept. 26, 2011 Letter to Secretary Sebelius, Health and Human Services Sen. Robert Casey Washington, DC
Sept. 23, 2011 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - "Examining the Increase in Drug Shortages" Rep. Joseph Pitts Washington, DC
Aug. 22, 2011 Meehan Calls for Nationwide Ban on "Bath Salts" Rep. Patrick Meehan Springfield, PA
July 28, 2011 Sens. Casey, Toomey and Wyden Introduce Bipartisan Bill to Encourage Treatments for Rare Diseases Sen. Robert Casey Washington, DC
July 28, 2011 Sens. Casey, Toomey and Wyden Introduce Bipartisan Bill to Encourage Treatments for Rare Diseases Sen. Patrick Toomey Washington, DC
July 28, 2011 Dent Bill to Ban Synthetic Drugs Passes Energy & Commerce Committee Rep. Charles Dent Washington, DC
July 25, 2011 GOP Doctors Caucus Rep. Timothy Murphy Washington, DC
July 21, 2011 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Legislative Hearing to Address Bioterrorism, Controlled Substances and Public Health Issues Rep. Joseph Pitts Washington, DC
July 21, 2011 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - "Legislative Hearing to Address Bioterrorism, Controlled Substances, and Public Health Issues" Rep. Charles Dent Washington, DC
July 21, 2011 Dent Testifies Before Health Subcommittee on Bill to Ban Synthetic Drugs Rep. Charles Dent Washington, DC
July 19, 2011 Casey Gratified by Senate Judiciary Move on Bath Salts, Urges DEA to Enact an Immediate Ban Sen. Robert Casey Washington, DC
July 7, 2011 Health Subcommittee Examines FDA Regulatory Process Rep. Joseph Pitts Washington, DC
June 27, 2011 Casey Pushes for Immediate Action on Prescription Drug Shortages Sen. Robert Casey Washington DC
June 16, 2011 Letter to The Honorable Margaret Hamburg, Commissioner, Food and Drug Administration Sen. Robert Casey Washington, DC
June 16, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 Rep. Glenn Thompson Washington, DC
June 3, 2011 Casey, Local Officials Discuss Anti-Drug Crime Strategies Sen. Robert Casey Williamsport, PA
May 24, 2011 Letter to Chairmen Whitehouse and Ranking Member Kyl: Casey to Judiciary Committee: Address Rx Drug Abuse, Gateway to Heroin Addiction Sen. Robert Casey Unknown
May 19, 2011 Dent and Mann Discuss Synthetic Drug Legislation Rep. Charles Dent Washington, DC
Back to top